Ken Milne MD
@TheSGEM
Remember to be skeptical of anything you learn, even if you heard it on the Skeptics’ Guide to EM. (he/him)
SGEM Xtra: Career Advice from Buffy the Vampire Slayer thesgem.com/2025/07/sgem-x…
Hey! Try not to get too worked up. #SGEMPeds is back this week with the 🍑 PEAChY-O trial. Olanzapine or Diazepam for pediatric agitation? buff.ly/3YPNAl2 Guest skeptic @PEMTweets joins us! @TheSGEM @PREDICT_network @AnnalsofEM #FOAMed #PedsEM
Analysis of scientific paper retractions due to data problems: Revealing challenges and countermeasures in data management tandfonline.com/doi/full/10.10…
Almost finished a wonderful week doing a module @UniofOxford with the @CebmOxford exploring evidence-based healthcare. Enjoyed the Rueben college venue.
Why AI chatbots lie to us | Science @DennisRenMD science.org/doi/10.1126/sc…
Big thanks to @TheSGEM (Dr. Ken Milne) who completely opened my eyes to this with his incredible lecture. youtube.com/watch?v=-4hZgE… /10
Importantly, there ideas about this that Dr. Ken Milne (@TheSGEM) reminds us SHOULD NOT BE parroted by politicians and media: ❌it's not 'non-urgent patients' ❌we don't need more 'fast tracks' ❌we don't need 'beds' (we need more staff) ❌triaging people away doesn't work /8
📍 Murcia, Spain | April 22–24, 2026 🎟️ Limited spots available (Plazas limitadas) @TheSGEM @SaraCrager @cliffreid @HedayatiMD @davidcarr333 @DocWillisMD @emcrit @ChorroRosanna @srrezaie @docib @HumanFact0rz @_NMay @stemlyns @Jailyn_Avi @umanamd
📌 𝐓𝐫𝐚𝐢𝐧 𝐚𝐬 𝐲𝐨𝐮 𝐰𝐨𝐫𝐤, 𝐰𝐨𝐫𝐤 𝐚𝐬 𝐲𝐨𝐮 𝐭𝐫𝐚𝐢𝐧. What will you take home from IncrEMentuM? - Realistic clinical simulation - Techniques you can apply on your next shift - Unfiltered international speakers - A high-level global community
There are serious problems with peer review. It kind of reminds me of Winston Churchill's famous quote. It is the worst form of quality control for the medical literature, except all the other that have been tried.
Giving a talk this morning in @UniofOxford at the @CebmOxford on how we could use AI to augment peer review.
This view never gets old 😍 📷 Instagram | ObservingOxford
Having a wonderful time in @UniofOxford disucssing the strengths & weaknesses of #EBM with amazing people from around the world @CebmOxford
Randomized trials in individual patients – N of 1 #RCTs - remain underutilized. This @AnnalsofIM paper describes our initial experience with 57 N of 1 RCTs. In 15, results prompted patients and clinicians to alter their treatment plans. pubmed.ncbi.nlm.nih.gov/2297206/
![TheSGEM's tweet card. Here are three tales of retractions and a puzzle. A tale of apparent benefit In a tweet on 16 April, the prolific Professor Mandeep R Mehra, whose 2020 PubMed record [...]More...](https://pbs.twimg.com/card_img/1946088797206188032/J9nlZSy5?format=jpg&name=orig)